LIGHT SCIENCES ONCOLOGY, INC.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 13, 2011 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 992 Total Citation Count
- Dec 04, 1996 Earliest Filing
- 23 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0008,372 ENHANCEMENT OF LIGHT ACTIVATED DRUG THERAPY THROUGH COMBINATION WITH OTHER THERAPEUTIC AGENTSAbandonedJul 08, 10Jan 13, 11[A61K, A61P]
2010/0305,436 SYSTEMS, DEVICES, AND METHODS FOR PHOTOACTIVE ASSISTED RESECTIONAbandonedSep 12, 08Dec 02, 10[A61B]
2009/0192,209 Extended treatment of tumors through vessel occlusion with light activated drugsAbandonedJan 07, 05Jul 30, 09[A61K]
2008/0269,846 DEVICE FOR TREATMENT OF BLOOD VESSELS USING LIGHTAbandonedApr 10, 08Oct 30, 08[A61B, A61N]
2007/0225,778 PDT apparatus with an addressable LED array for therapy and aimingAbandonedMar 23, 06Sep 27, 07[A61N]
2007/0059,316 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agentsAbandonedSep 23, 04Mar 15, 07[A61K, C07D, C07K]
2006/0229,284 Enhanced occlusive effect photodynamic therapyAbandonedDec 13, 05Oct 12, 06[A61K, A61H]
2006/0084,951 Low energy of excitation PDT compounds for treatment of ocular diseaseAbandonedSep 30, 05Apr 20, 06[A61B]
2005/0131,510 Device for distal protection and treatment of blood vesselsAbandonedJul 09, 04Jun 16, 05[A61N]
6554853 Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissueExpiredJul 20, 01Apr 29, 03[A61N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.